共 50 条
- [1] ASSESSMENT OF THE DRUG-DRUG INTERACTION POTENTIAL OF ELAFIBRANOR WITH WARFARIN IN HEALTHY ADULT MALE PARTICIPANTS: AN OPEN-LABEL PHASE I TRIALGASTROENTEROLOGY, 2024, 166 (05) : S1702 - S1703Pedret-Dunn, AnnaMazain, SarahAllan, RichardGattolliat, OlivierHanf, Remy
- [2] Assessment of the pharmacokinetic drug-drug interaction potential of elafibranor with atorvastatin in healthy adult male participants: an open-label phase I trialJOURNAL OF HEPATOLOGY, 2024, 80 : S337 - S338Pedret-Dunn, AnnaMazain, SarahAllan, RichardHanf, RemyAddy, Carol
- [3] The Pharmacokinetic Profile of Palovarotene: An Open-Label Phase I Trial Investigating the Effect of Food and Potential for Drug-Drug Interaction in Healthy ParticipantsEUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023, 48 (6) : 691 - 707Marino, RoseDube, LouiseOgier, JulienSang, Kim-Hanh Le Quan
- [4] The Pharmacokinetic Profile of Palovarotene: An Open-Label Phase I Trial Investigating the Effect of Food and Potential for Drug–Drug Interaction in Healthy ParticipantsEuropean Journal of Drug Metabolism and Pharmacokinetics, 2023, 48 : 691 - 707Rose MarinoLouise DubeJulien OgierKim-Hanh Le Quan Sang
- [5] Clinical Assessment of the Drug-Drug Interaction Potential of Omaveloxolone in Healthy Adult ParticipantsJOURNAL OF CLINICAL PHARMACOLOGY, 2025,Zahir, HamimMurai, MasakoWu, LucyValentine, MichelleHynes, Scott
- [6] Pharmacokinetics and Safety of Coadministered Atogepant and Topiramate in Healthy Participants: A Phase 1, Open-Label, Drug-Drug Interaction StudyCLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (10): : 1013 - 1021Boinpally, RameshMcGeeney, DanielleBorbridge, LisaTrugman, Joel
- [7] Randomized Open-Label Drug-Drug Interaction Trial of Dextromethorphan/Quinidine and Paroxetine in Healthy VolunteersCLINICAL DRUG INVESTIGATION, 2012, 32 (03) : 157 - 169Schoedel, Kerri A.Pope, Laura E.Sellers, Edward M.
- [8] Randomized Open-Label Drug-Drug Interaction Trial of Dextromethorphan/Quinidine and Paroxetine in Healthy VolunteersClinical Drug Investigation, 2012, 32 : 157 - 169Kerri A. SchoedelLaura E. PopeEdward M. Sellers
- [9] Pharmacokinetics and Safety of Atogepant Co-administered with Quinidine Gluconate in Healthy Participants: A Phase 1, Open-Label, Drug-Drug Interaction StudyCLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (08): : 930 - 937Boinpally, RameshBorbridge, LisaWangsadipura, Veronica
- [10] COADMINISTRATION OF CIMETIDINE WITH MIROGABALIN IN HEALTHY SUBJECTS: RESULTS FROM A PHASE I, RANDOMIZED, OPEN-LABEL, DRUG-DRUG INTERACTION STUDY.CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S49 - S49Tachibana, M.Yamamura, N.Hsu, C.Warren, V.Dishy, V.Zahir, H.